G Medical Innovations Holdings Ltd
G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in Israel. The company's products include Prizma, a multi-sensor device that measures vital signs and generate the health trend report; and Extended Holter Patch System, a multi-channel patient-worn… Read more
G Medical Innovations Holdings Ltd (GMVDF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2022: 13.249x
Based on the latest financial reports, G Medical Innovations Holdings Ltd (GMVDF) has a cash flow conversion efficiency ratio of 13.249x as of June 2022.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-16.43 Million) by net assets ($-1.24 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
G Medical Innovations Holdings Ltd - Cash Flow Conversion Efficiency Trend (2015–2022)
This chart illustrates how G Medical Innovations Holdings Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
G Medical Innovations Holdings Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of G Medical Innovations Holdings Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Eagle Royalties Ltd.
OTCGREY:ERYTF
|
-0.091x |
|
RCSL3F
SA:RCSL3F
|
N/A |
|
musicMagpie PLC
LSE:MMAG
|
0.302x |
|
CRBAF
PINK:CRBAF
|
0.082x |
|
MOONLIGHT FPO [ML8]
AU:ML8
|
N/A |
|
Third Bench Inc.
PINK:THBD
|
0.010x |
|
NIGERIAN AVIATION HANDLING CO. PLC
XNSA:NAHCO
|
N/A |
|
Lead Data Inc
TW:2443
|
-0.013x |
Annual Cash Flow Conversion Efficiency for G Medical Innovations Holdings Ltd (2015–2022)
The table below shows the annual cash flow conversion efficiency of G Medical Innovations Holdings Ltd from 2015 to 2022.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2022-12-31 | $-4.57 Million | $-18.48 Million | 4.043x | -1.10% |
| 2021-12-31 | $-2.81 Million | $-11.49 Million | 4.087x | +159.39% |
| 2020-12-31 | $-2.95 Million | $-4.65 Million | 1.576x | +147.14% |
| 2019-12-31 | $-9.88 Million | $-6.30 Million | 0.638x | -89.32% |
| 2018-12-31 | $-2.59 Million | $-15.46 Million | 5.968x | +1050.89% |
| 2017-12-31 | $13.21 Million | $-8.29 Million | -0.628x | -153.14% |
| 2015-12-31 | $-1.52 Million | $-1.79 Million | 1.181x | -- |